UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination

Human vaccines & immunotherapeutics, 2018-02, Vol.14 (2), p.337-344

2018

Volltextzugriff (PDF)

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

Journal of epidemiology and community health (1979), 2021-06, Vol.75 (6), p.489-495

2021

Volltextzugriff (PDF)

Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination

Scientific reports, 2021-07, Vol.11 (1), p.13664-13664, Article 13664

2021

Volltextzugriff (PDF)

Estimation of the infection attack rate of mumps in an outbreak among college students using paired serology

Epidemics, 2024-03, Vol.46, p.100751-100751, Article 100751

2024

Volltextzugriff (PDF)

Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months

Frontiers in immunology, 2022-02, Vol.13, p.817876-817876

2022

Volltextzugriff (PDF)

Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals

Viruses, 2022-07, Vol.14 (7), p.1570

2022

Volltextzugriff (PDF)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals

Viruses, 2022-12, Vol.15 (1), p.101

2022

Volltextzugriff (PDF)

Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis

PloS one, 2013-05, Vol.8 (5), p.e65157-e65157

2013

Volltextzugriff (PDF)

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

Frontiers in immunology, 2024-05, Vol.15, p.1392477-1392477

2024

Volltextzugriff (PDF)

Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults

Viruses, 2022-04, Vol.14 (4), p.797

2022

Volltextzugriff (PDF)

Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months

Frontiers in immunology, 2022-04, Vol.13, p.893720-893720

2022

Volltextzugriff (PDF)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

Vaccines (Basel), 2022-01, Vol.10 (1), p.132

2022

Volltextzugriff (PDF)

Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses

Vaccines (Basel), 2021-06, Vol.9 (7), p.699

2021

Volltextzugriff (PDF)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

BMC infectious diseases, 2012-02, Vol.12 (1), p.35-35, Article 35

2012

Volltextzugriff (PDF)

Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection

Vaccines (Basel), 2021-12, Vol.9 (12), p.1431

2021

Volltextzugriff (PDF)

Vaccination against Lyme disease: Are we ready for it?

Human vaccines & immunotherapeutics, 2016-03, Vol.12 (3), p.757-762

2016

Volltextzugriff (PDF)

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults

The Journal of infectious diseases, 2020-03, Vol.221 (6), p.902-909

2020

Volltextzugriff (PDF)

Identification of Naturally Processed Mumps Virus Epitopes by Mass Spectrometry: Confirmation of Multiple CD8+ T-Cell Responses in Mumps Patients

The Journal of infectious diseases, 2020-01, Vol.221 (3), p.474-482

2020

Volltextzugriff (PDF)

The Human CD4 + T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope

Journal of virology, 2019-03, Vol.93 (6)

2019

Volltextzugriff (PDF)

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?

Human vaccines & immunotherapeutics, 2013-06, Vol.9 (6), p.1263-1267

2013

Volltextzugriff (PDF)

Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory

Journal of allergy and clinical immunology, 2018-05, Vol.141 (5), p.1908-1911.e12

2018

Volltextzugriff (PDF)

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection

Vaccine, 2016-07, Vol.34 (35), p.4166-4171

2016

Volltextzugriff (PDF)

Routine vaccination against MenB: Considerations for implementation

Human vaccines & immunotherapeutics, 2014-02, Vol.10 (2), p.310-316

2014

Volltextzugriff (PDF)

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose

Open forum infectious diseases, 2020-11, Vol.7 (11), p.ofaa505-ofaa505

2020

Volltextzugriff (PDF)

Development of an IFNγ ELISPOT for the analysis of the human T cell response against mumps virus

Journal of immunological methods, 2016-04, Vol.431, p.52-59

2016

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination

Estimation of the infection attack rate of mumps in an outbreak among college students using paired serology

Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months

Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals

Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults

Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection

Vaccination against Lyme disease: Are we ready for it?

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults

Identification of Naturally Processed Mumps Virus Epitopes by Mass Spectrometry: Confirmation of Multiple CD8+ T-Cell Responses in Mumps Patients

The Human CD4 + T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?

Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection

Routine vaccination against MenB: Considerations for implementation

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose

Development of an IFNγ ELISPOT for the analysis of the human T cell response against mumps virus

Suchergebnisse filtern